Performing Smartness Differently - Strategic Enactments of a Global Imaginary in Three European Cities

In the scholarly literature on smart city, normative and prescriptive approaches dominate. Most publications with analytic goals focus on transnational corporations, the related global imaginary of a smart city, and on associated new technologies. In comparison, actually existing smart cities have seldom been investigated. This is even more the case for public governance arrangements of smart city policies. Our study compares three EU cities in this regard, which are attempting to take a lead in smart city development. In addition, urban agriculture and citizens' participation are specifically investigated in their relation to smart city policy-making. Based on policy document and media discourse analysis, interviews, and participant observation, three governance arrangements of smart city policies are identified: hierarchical governance by the government in Barcelona between 2011 and 2015, closed co-governance by the city executive and non-governmental actors in Vienna and since 2015 in Barcelona, and open co-governance in Berlin. Citizens' participation is in the center in Barcelona since 2015, and is potentially important in Berlin. The Viennese smart city governance arrangement is characterized by non-hierarchical bargaining within the administration and signals innovative meta-governance, without citizens' participation. In all three cities, international dynamics play a crucial role for engaging with smart city, but it is enacted in particular ways according to place-specific history, social forces, and economic and political conditions. The meaning of smart city varies thus considerably: a comprehensive urban sustainability strategy focused upon climate policy goals in Vienna; a comprehensive internationalization strategy in Barcelona between 2011 and 2015; a limited technology- and business-oriented approach in Berlin; and a limited digital city frame geared to participatory democracy and technological sovereignty in Barcelona since 2015. Contrary to the literature, we highlight the agency of city executives, and the place-specific enactments that global smart city imaginaries undergo. Current smart city policies express more continuity than rupture with regard to urban development policies in our case study cities.Series: SRE - Discussion Paper

Gemeinschaftsgärten als räumlicher Ausdruck von Organisationsstrukturen. Erkundungen am Beispiel Wien

Der Artikel untersucht Gemeinschaftsgärten in Wien unter dem Blickwinkel einer grundlegenden Transformation der Matrix des gegenwärtigen urbanen Raums hin zu einem differenziellen Raum (Lefebvre). Dies geschieht, indem wir anhand von acht Fallstudien Projekte mit unterschiedlich starkem staatlichem Einfluss vergleichen. Wir untersuchen, inwiefern die lokalstaatlich beeinflussten Gärten Anforderungen an die Lesbarkeit sozialräumlicher Verhältnisse durch den Staat erkennbar verkörpern, und sich damit in die Matrix des abstrakten, bürokratisch geprägten Raums bruchlos einfügen. Im Gegensatz dazu zeigen die vom Staat nicht direkt beeinflussten Gärten einen geringeren Grad von Lesbarkeit undwidersprechen der umgebenden Raummatrix deutlicher. Wir arbeiten heraus, dass Gärten, in denen der staatliche Einfluss stärker ist, in ihrem Binnenraum sowie im Vergleich miteinander homogener sind als Gärten, in denen staatlicher Einfluss keine oder eine geringe Rolle spielt. Es wird deutlich, dass eine bloße Ästhetisierung des Raums über die Markierung von Differenzen für eine Überwindung des abstrakten Raums nicht ausreicht

Site-specific conjugation of 8-ethynyl-BODIPY to a protein by [2+3] cycloaddition

We report a straightforward synthesis of 8-ethynyl-BODIPY derivatives and their potential as fluorescent labeling compounds using an alkyne-azide click chemistry approach. The ethynyl substituted BODIPY dyes at the meso-position were reacted under Cu+ catalysis and mild physiological conditions in organic and biological model systems using benzyl azide and a Barstar protein which was selectively modified by a single amino acid substituted methionine at the N-terminus (Met1). azidohomoalanine (Aha). Conjugation with the protein and the model azide was indicated by a significant blue shift upon formation of the triazole moiety system, which allowed easy distinction between free and coupled dyes. This blue shift was rationalized by the perpendicular orientation of the triazole relative to the chromophore using time dependent density functional theory (TDDFT) calculations. A full spectroscopic and thermodynamic characterization of the protein revealed that a fluorophore was incorporated without the cross influence of protein stability and functional integrity. Furthermore, model reactions of 8-ethynyl-BODIPY derivatives with benzyl azide under copper-free conditions indicate second order kinetics with high rate constants comparable with those found for the strain-promoted azide-alkyne cycloaddition (SPAAC). In this way, we establish a unique and highly efficient method to introduce alkyne-BODIPY into a protein scaffold potentially useful for diverse applications in areas ranging from fundamental protein dynamics studies to biotechnology or cell biology

Exploiting transient protein states for the design of small-molecule stabilizers of mutant p53

The destabilizing p53 cancer mutation Y220C creates an extended crevice on the surface of the protein that can be targeted by small-molecule stabilizers. Here, we identify different classes of small molecules that bind to this crevice and determine their binding modes by X-ray crystallography. These structures reveal two major conformational states of the pocket and a cryptic, transiently open hydrophobic subpocket that is modulated by Cys220. In one instance, specifically targeting this transient protein state by a pyrrole moiety resulted in a 40-fold increase in binding affinity. Molecular dynamics simulations showed that both open and closed states of this subsite were populated at comparable frequencies along the trajectories. Our data extend the framework for the design of high-affinity Y220C mutant binders for use in personalized anticancer therapy and, more generally, highlight the importance of implementing protein dynamics and hydration patterns in the drug-discovery process

Spatial transcriptome analysis reveals Notch pathway-associated prognostic markers in IDH1 wild-type glioblastoma involving the subventricular zone

Background: The spatial relationship of glioblastoma (GBM) to the subventricular zone (SVZ) is associated with inferior patient survival. However, the underlying molecular phenotype is largely unknown. We interrogated an SVZ-dependent transcriptome and potential location-specific prognostic markers. Methods: mRNA microarray data of a discovery set (n = 36 GBMs) were analyzed for SVZ-dependent gene expression and process networks using the MetaCore™ workflow. Differential gene expression was confirmed by qPCR in a validation set of 142 IDH1 wild-type GBMs that was also used for survival analysis. Results: Microarray analysis revealed a transcriptome distinctive of SVZ+ GBM that was enriched for genes associated with Notch signaling. No overlap was found to The Cancer Genome Atlas’s molecular subtypes. Independent validation of SVZ-dependent expression confirmed four genes with simultaneous prognostic impact: overexpression of HES4 (p = 0.034; HR 1.55) and DLL3 (p = 0.017; HR 1.61) predicted inferior, and overexpression of NTRK2 (p = 0.049; HR 0.66) and PIR (p = 0.025; HR 0.62) superior overall survival (OS). Additionally, overexpression of DLL3 was predictive of shorter progression-free survival (PFS) (p = 0.043; HR 1.64). Multivariate analysis revealed overexpression of HES4 to be independently associated with inferior OS (p = 0.033; HR 2.03), and overexpression of DLL3 with inferior PFS (p = 0.046; HR 1.65). Conclusions: We identified four genes with SVZ-dependent expression and prognostic significance, among those HES4 and DLL3 as part of Notch signaling, suggesting further evaluation of location-tailored targeted therapies

The role of FAIR nanosafety data and nanoinformatics in achieving the UN sustainable development goals: the NanoCommons experience†

The increasing focus on open and FAIR (Findable, Accessible, Interoperable and Re-useable) data is driving a step-change in how research communities and governments think about data and knowledge, and the potential for re-use of data. It has long been recognised that international data sharing is essential for regulatory harmonisation and commercialisation, via the Mutual Acceptance of Data (MAD) principle of the Organisation for Economic Cooperation and Development (OECD) for example. However, it is interesting to note that despite the power of data and data-driven software to support the achievement of the United Nations Sustainable Development Goals (UN SDGs), there appears to be limited awareness of how nanomaterials environmental health and safety (nano EHS) data can drive progress towards many of the SDGs. The goal of the NanoCommons research infrastructure project was to increase FAIRness and impact of nanoEHS data through development of services, including data shepherding to support researchers across the data life cycle and tools such as user-friendly nanoinformatics predictive models. We surveyed both service providers and service users on their ideas regarding how nanoEHS data might support the SDGs, and discovered a significant lack of awareness of the SDGs in general, and the potential for impact from NanoCommons tools and services. To address this gap, a workshop on the SDGs was prepared and delivered to support the NanoCommons service providers to understand the SDGs and how nanosafety data and nanoinformatics can support their achievement. Following the workshop, providers were invited to update their questionnaire responses. The results from the workshop discussions are presented, along with a summary of the 12 SDGs identified where increasingly accessible nanoEHS data will have a significant impact, and the 5 that are indirectly benefited along with some recommendations for EU-funded projects on how they can maximise and monitor their contributions to the SDGs

Harmonising knowledge for safer materials via the “NanoCommons” Knowledge Base

In mediaeval Europe, the term “commons” described the way that communities managed land that was held “in common” and provided a clear set of rules for how this “common land” was used and developed by, and for, the community. Similarly, as we move towards an increasingly knowledge-based society where data is the new oil, new approaches to sharing and jointly owning publicly funded research data are needed to maximise its added value. Such common management approaches will extend the data’s useful life and facilitate its reuse for a range of additional purposes, from modelling, to meta-analysis to regulatory risk assessment as examples relevant to nanosafety data. This “commons” approach to nanosafety data and nanoinformatics infrastructure provision, co-development, and maintenance is at the heart of the “NanoCommons” project and underpins its post-funding transition to providing a basis on which other initiatives and projects can build. The present paper summarises part of the NanoCommons infrastructure called the NanoCommons Knowledge Base. It provides interoperability for nanosafety data sources and tools, on both semantic and technical levels. The NanoCommons Knowledge Base connects knowledge and provides both programmatic (via an Application Programming Interface) and a user-friendly graphical interface to enable (and democratise) access to state of the art tools for nanomaterials safety prediction, NMs design for safety and sustainability, and NMs risk assessment, as well. In addition, the standards and interfaces for interoperability, e.g., file templates to contribute data to the NanoCommons, are described, and a snapshot of the range and breadth of nanoinformatics tools and models that have already been integrated are presented Finally, we demonstrate how the NanoCommons Knowledge Base can support users in the FAIRification of their experimental workflows and how the NanoCommons Knowledge Base itself has progressed towards richer compliance with the FAIR principles

Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients

Background: To date, standardized strategies for the treatment of recurrent glioma are lacking. Chemotherapy with the alkylating agent BCNU (1,3-bis (2-chloroethyl)-1-nitroso-urea) is a therapeutic option even though its efficacy and safety, particularly the risk of pulmonary fibrosis, remains controversial. To address these issues, we performed a retrospective analysis on clinical outcome and side effects of BCNU-based chemotherapy in recurrent glioma. Methods: Survival data of 34 mostly chemotherapy-naïve glioblastoma patients treated with BCNU at 1st relapse were compared to 29 untreated control patients, employing a multiple Cox regression model which considered known prognostic factors including MGMT promoter hypermethylation. Additionally, medical records of 163 patients treated with BCNU for recurrent glioma WHO grade II to IV were retrospectively evaluated for BCNU-related side effects classified according to the National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE) version 2.0. Results: In recurrent glioblastoma, multiple regression survival analysis revealed a significant benefit of BCNU-based chemotherapy on survival after relapse (p = 0.02; HR = 0.48; 95 % CI = 0.26–0.89) independent of known clinical and molecular prognostic factors. Exploratory analyses suggested that survival benefit was most pronounced in MGMT-hypermethylated, BCNU-treated patients. Moreover, BCNU was well tolerated by 46 % of the 163 patients analyzed for side effects; otherwise, predominantly mild side effects occurred (CTCAE I/II; 45 %). Severe side effects CTCAE III/IV were observed in 9 % of patients including severe hematotoxicity, thromboembolism, intracranial hemorrhage and injection site reaction requiring surgical intervention. One patient presented with a clinically apparent pulmonary fibrosis CTCAE IV requiring temporary mechanical ventilation. Conclusion: In this study, BCNU was rarely associated with severe side effects, particularly pulmonary toxicity, and, in case of recurrent glioblastoma, even conferred a favorable outcome. Therefore BCNU appears to be an appropriate alternative to other nitrosoureas although the efficacy against newer drugs needs further evaluation

Genetic Analyses of Heme Oxygenase 1 (HMOX1) in Different Forms of Pancreatitis

Contains fulltext : 107993.pdf (publisher's version ) (Open Access)BACKGROUND: Heme oxygenase 1 (HMOX1) is the rate limiting enzyme in heme degradation and a key regulator of inflammatory processes. In animal models the course of pancreatitis was ameliorated by up-regulation of HMOX1 expression. Additionally, carbon monoxide released during heme breakdown inhibited proliferation of pancreatic stellate cells and might thereby prevent the development of chronic pancreatitis (CP). Transcription of HMOX1 in humans is influenced by a GT-repeat located in the promoter. As such, HMOX1 variants might be of importance in the pathogenesis of pancreatitis. METHODS: The GT-repeat and SNP rs2071746 were investigated with fluorescence labelled primers and by melting curve analysis in 285 patients with acute pancreatitis, 208 patients with alcoholic CP, 207 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and in 289 controls, respectively. GT-repeat analysis was extended to a total of 446 alcoholic CP patients. In addition, we performed DNA sequencing in 145 patients with alcoholic CP, 138 patients with idiopathic/hereditary CP, 147 patients with alcoholic liver cirrhosis, and 151 controls. Exon 3 screening was extended to additional patients and controls. RESULTS: S- and L-alleles of the GT-repeat, genotypes and alleles of SNP rs2071746 and non-synonymous variants detected by sequencing were found with similar frequencies in all groups. CONCLUSIONS: Although functional data implicate a potential influence of HMOX1 variants on the pathogenesis of pancreatitis, we did not find any association. As rare non-synonymous HMOX1 variants were found in patients and controls, it is rather unlikely that they will have functional consequences essential for pancreatitis development